Doxorubicin liposomal companion diagnostic - Oncology Venture

Drug Profile

Doxorubicin liposomal companion diagnostic - Oncology Venture

Alternative Names: Doxorubicin liposomal DRP™

Latest Information Update: 06 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Oncology Venture
  • Class Diagnostic agents
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Breast cancer

Most Recent Events

  • 04 Apr 2017 9213713 - new profile
  • 28 Mar 2017 Preclinical trials in Cancer in Denmark before March 2017
  • 28 Mar 2017 Oncology Venture plans a phase II trial for Breast cancer (Metastatic disease) in Denmark
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top